Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
3.000
-0.160 (-5.06%)
Mar 31, 2025, 2:07 PM EDT - Market open

Artiva Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
73245----
Upgrade
Enterprise Value
-94113----
Upgrade
Last Close Price
3.1610.08----
Upgrade
Debt / Equity Ratio
0.080.080.310.260.010.13
Upgrade
Asset Turnover
0.000.000.280.030.02-
Upgrade
Quick Ratio
15.2215.226.454.028.364.41
Upgrade
Current Ratio
15.4015.406.534.098.414.53
Upgrade
Return on Equity (ROE)
-54.24%-54.24%-44.15%-57.84%-99.72%-286.85%
Upgrade
Return on Assets (ROA)
-26.72%-26.72%-16.10%-24.68%-33.43%-67.03%
Upgrade
Return on Capital (ROIC)
-30.89%-30.89%-23.03%-33.32%-45.02%-101.60%
Upgrade
Buyback Yield / Dilution
-1302.54%-1302.54%-4.70%-11.80%-8.60%-3.59%
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q